Identification of signature genes for detecting hedgehog signaling activation in gastric cancer

Molecular Medicine Reports

Volumn 3, Issue 3, 2010, Pages 473-478

  Yang, Ling ^a   Huang, Shuhong ^a   Bian, Yuehong ^a   Ma, Xiaoli ^a   Zhang, Hongwei ^a   Xie, Jingwu ^b  

^a SHANDONG UNIVERSITY   (China)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastric cancer; Hedgehog; Hedgehog interacting protein; PDGFR ; Smoothened; Suppressor of fused

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; RNA; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME ACTIVATION; FEMALE; GASTRITIS; GENE IDENTIFICATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STOMACH CANCER;

ERINACEIDAE;

EID: 77952337262     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000283     Document Type: Article

References (37)

1. Van den Brink GR, Hardwick JC, Tytgat GN, et al: Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology 121: 317-328, 2001.
2. Kim JH, Huang Z and Mo R: Gli3 null mice display glandular overgrowth of the developing stomach. Dev Dyn 234: 984-991, 2005.
3. Van den Brink GR, Hardwick JC, Nielsen C, et al: Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract. Gut 51: 628-633, 2002. (Pubitemid 35216847)
4. Kang DH, Han ME, Song MH, et al: The role of hedgehog signaling during gastric regeneration. J Gastroenterol 44: 372-379, 2009.
5. Madison BB, McKenna LB, Dolson D, Epstein DJ and Kaestner KH: FoxF1 and FoxL1 link hedgehog signaling and the control of epithelial proliferation in the developing stomach and intestine. J Biol Chem 284: 5936-5944, 2009.
6. Ohta H, Aoyagi K, Fukaya M, et al: Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers. Br J Cancer 100: 389-398, 2009.
7. Osawa H, Ohnishi H, Takano K, et al: Sonic hedgehog stimulates the proliferation of rat gastric mucosal cells through ERK activation by elevating intracellular calcium concentration. Biochem Biophys Res Commun 344: 680-687, 2006.
8. Ramalho-Santos M, Melton DA and McMahon AP: Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 127: 2763-2772, 2000.
9. Haveri H, Westerholm-Ormio M, Lindfors K, et al: Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa. BMC Gastroenterol 8: 9, 2008.
10. Wang LH, Choi YL, Hua XY, et al: Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions. Mod Pathol 19: 675-683, 2006.
11. Yanai K, Nagai S, Wada J, et al: Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. J Surg Oncol 95: 55-62, 2007. (Pubitemid 46122719)
12. Ohta M, Tateishi K, Kanai F, et al: p53-independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. Cancer Res 65: 10822-10829, 2005.
13. Yanai K, Nakamura M, Akiyoshi T, et al: Crosstalk of hedgehog and Wnt pathways in gastric cancer. Cancer Lett 263: 145-156, 2008.
14. Yoo YA, Kang MH, Kim JS and Oh SC: Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Carcinogenesis 29: 480-490, 2008.
15. Ma X, Chen K, Huang S, et al: Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 26: 1698-1705, 2005. (Pubitemid 41487985)
16. Sarbia M, Becker KF and Hofler H: Pathology of upper gastrointestinal malignancies. Semin Oncol 31: 465-475, 2004.
17. Bonifas JM, Pennypacker S, Chuang PT, et al: Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol 116: 739-742, 2001.
18. Sheng T, Li C, Zhang X, et al: Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer 3: 29, 2004.
19. Xie J, Aszterbaum M, Zhang X, et al: Arole of PDGFRalpha in basal cell carcinoma proliferation. Proc Natl Acad Sci USA 98: 9255-9259, 2001.
20. Wijgerde M, McMahon JA, Rule M and McMahon AP: Adirect requirement for Hedgehog signaling for normal specification of all ventral progenitor domains in the presumptive mammalian spinal cord. Genes Dev 16: 2849-2864, 2002. (Pubitemid 35334735)
21. Karhadkar SS, Bova GS, Abdallah N, et al: Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431: 707-712, 2004.
22. Barnfield PC, Zhang X, Thanabalasingham V, Yoshida M and Hui CC: Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms. Differentiation 73: 397-405, 2005. (Pubitemid 43922158)
23. Chi S, Huang S, Li C, et al: Activation of the hedgehog pathway in a subset of lung cancers. Cancer Lett 244: 53-60, 2006. (Pubitemid 44485862)
24. Taniguchi H, Yamamoto H, Akutsu N, et al: Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. J Pathol 213: 131-139, 2007.
25. Svard J, Heby-Henricson K, Persson-Lek M, et al: Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev Cell 10: 187-197, 2006.
26. Reifenberger J, Wolter M, Knobbe CB, et al: Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 152: 43-51, 2005. (Pubitemid 40193831)
27. Taylor MD, Liu L, Raffel C, et al: Mutations in SUFUpredispose to medulloblastoma. Nat Genet 31: 306-310, 2002.
28. Kasai K, Inaguma S, Yoneyama A, Yoshikawa K and Ikeda H: SCL/TAL1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cells. Cancer Res 68: 7723-7729, 2008.
29. Rikova K, Guo A, Zeng Q, et al: Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203, 2007.
30. Taja-Chayeb L, Chavez-Blanco A, Martinez-Tlahuel J, et al: Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer. Cancer Cell Int 6: 22, 2006.
31. Zhang T, Sun HC, Xu Y, et al: Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential. Clin Cancer Res 11: 8557-8563, 2005. (Pubitemid 43005900)
32. Matei D, Emerson RE, Lai YC, et al: Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer. Oncogene 25: 2060-2069, 2006.
33. Jechlinger M, Sommer A, Moriggl R, et al: Autocrine PDGFRsignaling promotes mammary cancer metastasis. J Clin Invest 116: 1561-1570, 2006. (Pubitemid 43911010)
34. Lev DC, Kim SJ, Onn A, et al: Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. Clin Cancer Res 11: 306-314, 2005. (Pubitemid 40075809)
35. Russell MR, Jamieson WL, Dolloff NG and Fatatis A: The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells. Oncogene 28: 412-421, 2009.
36. Wehler TC, Frerichs K, Graf C, et al: PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy. Oncol Rep 19: 697-704, 2008. (Pubitemid 351330438)
37. Heinrich MC, Corless CL, Demetri GD, et al: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21: 4342-4349, 2003.